Zofran is an anti-nausea drug used to help people with cancers that are receiving treatments, and people who have recently had surgery. In addition, the FDA has only approved Zofran use for these conditions, yet the makers of the drug have been found to market it as effect treatment for morning sickness in pregnant women. Consequently, many women who have used Zofran during pregnancy are delivering babies with life-altering birth defects. Such defects include cleft palate, cleft lip, and heart defects.
GlaxoSmithKline (GSK) is the makers of Zofran and has paid out millions already for allegedly offering financial compensation to physicians for pushing the drug to pregnant patients. Likewise, current lawsuits are alleging that GSK knew that Zofran was unsafe for use during pregnancy, yet ignored the warnings and heavily promoted the drug for such women. Now, families of babies born with birth defects that took Zofran while pregnant are suing the pharmaceutical giant for negligence. GSK has even been receiving notices from families advising them of the outcomes of taking Zofran while pregnant. Sadly the company chose to ignore them until now.
It was found during animal testing it was found that Zofran is unsafe for use during pregnancy because it reaches past the placental barrier. The FDA has also placed the drug in category B that is deemed unsafe for use while pregnant. Currently, the skilled St. Louis personal injury attorneys at Meyerkord & Kurth are representing Zofran cases. If Zofran use or any other drug has injured you or a loved one, we can help. Please contact us today for a free consultation.